By making this decision he wasn’t guaranteeing a loss in revenue for the company. By not producing the drug he was guaranteeing that people would die unnaturally or have a severely reduced quality of life. The decision he made could not only be seen as an effective way to save lives, but could have also been used effectually as a marketing campaign for the company itself. Marketing makes up a major percentage of prescription drug companies budgets in the U.S. I think it could be argued that had Vagelos not researched the drug he would have made an immoral decision by the company as well as the individuals who were helped by it. In fact, in a study recently published showed that 9 out of 10 of the largest pharmaceutical companies spend more on marketing than they do on R&D. Merck specifically spends 9.5 billion on marketing and sales while only spending 7.5 billion on research and development. The $200 million (and 3.5 billion) that it would cost to research and distribute the drug are close to a third of the company's yearly marketing budget. In conclusion, I believe the company made a morally correct decision by producing Mectizan for not only the people saved but also their company as
By making this decision he wasn’t guaranteeing a loss in revenue for the company. By not producing the drug he was guaranteeing that people would die unnaturally or have a severely reduced quality of life. The decision he made could not only be seen as an effective way to save lives, but could have also been used effectually as a marketing campaign for the company itself. Marketing makes up a major percentage of prescription drug companies budgets in the U.S. I think it could be argued that had Vagelos not researched the drug he would have made an immoral decision by the company as well as the individuals who were helped by it. In fact, in a study recently published showed that 9 out of 10 of the largest pharmaceutical companies spend more on marketing than they do on R&D. Merck specifically spends 9.5 billion on marketing and sales while only spending 7.5 billion on research and development. The $200 million (and 3.5 billion) that it would cost to research and distribute the drug are close to a third of the company's yearly marketing budget. In conclusion, I believe the company made a morally correct decision by producing Mectizan for not only the people saved but also their company as